Clinical Trial Update: ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs [Phase 4]

View source ↗

Summary

This update reports the completion of the Phase 4 ZAGAL trial evaluating zonisamide as adjunctive therapy for partial-onset seizures in patients on two antiepil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Zonisamide (zonisamide)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED